Clinical Trial Update: Endoxifen in Adults With Hormone Receptor Positive Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of endoxifen in adults with hormone receptor-positive solid tumors; the study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Desmoid-type Fibromatosis
• Gynecologic Cancer
• Hormone Receptor-positive Neoplasms

Drugs mentioned

• Endoxifen (Endoxifen)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Hormone Receptor-Positive Breast, Gynecologic | Phase 1 | Status: COMPLETED